A systems biology approach to suppress TNF-induced proinflammatory gene expressions

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Hayashi, Kentaro ^a   Piras, Vincent ^a   Tabata, Sho ^a   Tomita, Masaru ^a   Selvarajoo, Kumar ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cell signaling; Computational model; Inflammation; RIP1; TNF

Indexed keywords

AUTOTAXIN; COLLAGENASE 3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NECROSTATIN 1; PROTEIN INHIBITOR; STROMELYSIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AGFG1 PROTEIN, HUMAN; NUCLEOPORIN; RNA BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; CCL7 GENE; COMPUTER MODEL; CONTROLLED STUDY; CXCL10 GENE; EMBRYO; ENPP2 GENE; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; IL6 GENE; INFLAMMATION; JUN GENE; MMP13 GENE; MMP3 GENE; MOUSE; NFKBIA GENE; NONHUMAN; PRIORITY JOURNAL; RIP1 GENE; SYSTEMS BIOLOGY; TNFAIP3 GENE; UPREGULATION; VALIDATION STUDY; VCAM1 GENE; 3T3 CELL LINE; ANIMAL; GENE EXPRESSION; METABOLISM; SIGNAL TRANSDUCTION;

MURINAE;

3T3 CELLS; ANIMALS; GENE EXPRESSION; INFLAMMATION; MICE; NF-KAPPA B; NUCLEAR PORE COMPLEX PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR NECROSIS FACTORS;

EID: 84887338354     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-84     Document Type: Article

References (56)

1. Action of bacterial polysaccharide on tumours: II: damage of sarcoma 37 by serum of mice treated with serratia marcescens polysaccharide, and induced tolerance. O'Malley WE, Achinstein B, Shear MJ, J Natl Cancer Inst 1962 29 1169 1175
2. Tumour necrosis factor and cancer. Balkwill F, Nat Rev Cancer 2009 9 361 371 10.1038/nrc2628 19343034
3. The TNF and TNF receptor superfamilies: integrating mammalian biology. Locksley RM, Killeen N, Lenardo MJ, Cell 2001 104 487 501 10.1016/S0092-8674(01) 00237-9 11239407 (Pubitemid 32201945)
4. TNF-mediated inflammatory disease. Bradley JR, J Pathol 2008 214 149 160 10.1002/path.2287 18161752 (Pubitemid 351160153)
5. TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. van Horssen R, Ten Hagen TL, Eggermont AM, Oncologist 2006 4 397 408
6. Innate immunity: regulation of caspases by IAP-dependent ubiquitylation. Falschlehner C, Boutros M, EMBO J 2012 31 2750 2752 10.1038/emboj.2012.148 22588080
7. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κ;B activation protection from cell death. Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, Yeh WC, Nakano H, J Biol Chem 2001 276 36530 36534 10.1074/jbc.M104837200 11479302
8. TRAF6 negatively regulates TNFα-induced NF-κB activation. Funakoshi-Tago M, Kamada N, Shimizu T, Hashiguchi Y, Tago K, Sonoda Y, Kasahara T, Cytokine 2009 45 72 79 10.1016/j.cyto.2008.10.010 19091594
9. Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability. Fallahi-Sichani M, Flynn JL, Linderman JJ, Kirschner DE, J Immunol 2012 188 3169 3178 10.4049/jimmunol. 1103298 22379032
10. Meta-analysis of the efficacy and safety of Adalimumab, Etanercept, and Infliximab for the treatment of rheumatoid arthritis. Wiens A, Venson R, Correr CJ, Otuki MF, Pontarolo R, Pharmacotherapy 2010 30 339 353 10.1592/phco.30.4.339 20334454
11. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Ermolaeva MA, Michallet MC, Papadopoulou N, Utermöhlen O, Kranidioti K, Kollias G, Tschopp J, Pasparakis M, Nat Immunol 2008 9 1037 1046 10.1038/ni.1638 18641654
12. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Hao S, Baltimore D, Nat Immunol 2009 10 281 288 19198593
13. Determination of complex reaction mechanisms: analysis of chemical, biological and genetic networks. Ross J, J Phys Chem A 2008 112 2134 2143 10.1021/jp711313e 18275175
14. Species connectivities and reaction mechanisms from neutral response experiments. Moran F, Vlad MO, Bustos M, Trivino JC, Ross J, J Phys Chem A 2007 111 1844 1851 10.1021/jp0661793 17309244 (Pubitemid 46543238)
15. Can complex cellular processes be governed by simple linear rules? Selvarajoo K, Tomita M, Tsuchiya M, J Bioinform Comput Biol 2009 7 243 268 10.1142/S0219720009003947 19226669
16. Determination of causal connectivities of species in reaction networks. Vance W, Arkin A, Ross J, Proc Natl Acad Sci USA 2002 99 5816 5821 10.1073/pnas.022049699 11983885 (Pubitemid 34493222)
17. Discovering differential activation machinery of the toll-like receptor 4 signaling pathways in MyD88 knockouts. Selvarajoo K, FEBS Lett 2006 580 1457 1464 10.1016/j.febslet.2006.01.046 16458306 (Pubitemid 43222015)
18. Signaling flux redistribution at toll-like receptor pathway junctions. Selvarajoo K, Takada Y, Gohda J, Helmy M, Akira S, Tomita M, Tsuchiya M, Inoue J, Matsuo K, PLoS ONE 2008 3 3430 DOI:10.1371/journal.pone.0003430 10.1371/journal.pone.0003430 18927610
19. Predicting novel features of Toll-like receptor 3 signaling in macrophages. Helmy M, Gohda J, Inoue J, Tomita M, Tsuchiya M, Selvarajoo K, PLoS ONE 2009 4 4661 DOI: 10.1371/journal.pone.0004661 10.1371/journal.pone.0004661 19252739
20. Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules. Piras V, Hayashi K, Tomita M, Selvarajoo K, Sci Rep 2011 1 144 DOI:10.1038/srep00144 22355661
21. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z, Immunity 2000 12 419 429 10.1016/S1074- 7613(00)80194-6 10795740
22. Regulation of death receptor signaling by the ubiquitin system. Wertz IE, Dixit VM, Cell Death Differ 2010 17 14 24 10.1038/cdd.2009.168 19893571
23. COPASI-a COmplex PAthway SImulator. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U, Bioinformatics 2006 22 3067 3074 10.1093/bioinformatics/btl485 17032683 (Pubitemid 44884083)
24. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Werner SL, Barken D, Hoffmann A, Science 2005 309 1857 1861 10.1126/science.1113319 16166517 (Pubitemid 41325096)
25. Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems. Tasseff R, Nayak S, Salim S, Kaushik P, Rizvi N, Varner JD, PLoS One 2010 5 8864 DOI:10.1371/journal.pone.0008864 10.1371/journal.pone.0008864 20126616
26. Chemical laser modelling with genetic algorithms. Carroll DA, AIAA 1996 34 338 346 10.2514/3.13069
27. Encoding NF-κ;B temporal control in response to TNF: distinct roles for the negative regulators Iκ;B and A20. Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O'Dea E, Boldin MP, Ma A, Baltimore D, Hoffmann A, Genes Dev 2008 22 2093 2101 10.1101/gad.1680708 18676814
28. Investigations into the analysis and modeling of the TNF α;-mediated NF-κ; B-signaling pathway. Cho KH, Shin SY, Lee HW, Wolkenhauer O, Genome Res 2003 13 2413 2422 10.1101/gr.1195703 14559780 (Pubitemid 37428265)
29. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Kholodenko BN, Eur J Biochem 2000 267 1583 1588 10.1046/j.1432-1327.2000.01197.x 10712587 (Pubitemid 30165509)
30. RNA splicing regulates the temporal order of TNF-induced gene expression. Hao S, Baltimore D, Proc Natl Acad Sci U S A 2013 110 11934 11939 10.1073/pnas.1309990110 23812748
31. A TNF-induced gene expression program under oscillatory NF-κ;B control. Tian B, Nowak DE, Brasier AR, BMC Genomics 2005 6 137 154 10.1186/1471-2164-6-137 16191192 (Pubitemid 41418974)
32. Solomon EP, Berg LR, Martin DW, Biology Thomson Brooks/Cole: Pacific Grove 9 2011
33. Autocrine IL-1beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFα signalling to carcinoma-associated fibroblasts. Chaudhry SI, Hooper S, Nye E, Williamson P, Harrington K, Sahai E, Oncogene 2013 32 747 758 10.1038/onc.2012.91 22450746
34. Autocrine IL-6 signaling: a key event in tumorigenesis? Grivennikov S, Karin M, Cancer Cell 2008 13 7 9 10.1016/j.ccr.2007.12.020 18167335 (Pubitemid 350309747)
35. Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis. Ihn H, J Dermatol Sci 2008 49 103 113 10.1016/j.jdermsci.2007.05.014 17628443 (Pubitemid 350298736)
36. The Iκ;B-NF-κ;B signaling module: temporal control and selective gene activation. Hoffmann A, Levchenko A, Scott ML, Baltimore D, Science 2002 298 1241 1245 10.1126/science.1071914 12424381 (Pubitemid 35285493)
37. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. Tang M, Wei X, Guo Y, Breslin P, Zhang S, Zhang S, Wei W, Xia Z, Diaz M, Akira S, Zhang J, J Exp Med 2008 205 1611 1619 10.1084/jem.20080297 18573910 (Pubitemid 351962025)
38. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Lamothe B, Lai Y, Xie M, Schneider MD, Darnay BG, Mol Cell Biol 2013 33 582 595 10.1128/MCB.01225-12 23166301
39. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Degterev A, Huang Z, Boyce M, Nat Chem Biol 2005 1 112 119 10.1038/nchembio711 16408008
40. Identification of RIP1 kinase as a specific cellular target of necrostatins. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J, Nat Chem Biol 2008 4 313 321 10.1038/nchembio.83 18408713 (Pubitemid 351550892)
41. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor κ B (NF-κ B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Liacini A, Sylvester J, Li WQ, Zafarulla M, Matrix Biol 2002 21 251 262 10.1016/S0945-053X(02)00007-0 12009331 (Pubitemid 34497016)
42. Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M, Zafarullah M, Exp Cell Res 2003 288 208 217 10.1016/S0014-4827(03)00180-0 12878172 (Pubitemid 36871010)
43. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Sellam J, Berenbaum F, Nat Rev Rheumatol 2010 6 625 635 10.1038/nrrheum.2010.159 20924410
44. NF-κ;B as a potential therapeutic target in osteoarthritis. Roman-Blas JA, Jimenez MD, Osteoarthritis Cartilage 2006 14 839 848 10.1016/j.joca.2006.04.008 16730463 (Pubitemid 44138675)
45. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Santos SD, Verveer PJ, Bastiaens PI, Nat Cell Biol 2007 9 324 330 10.1038/ncb1543 17310240 (Pubitemid 46344612)
46. Modular response analysis of cellular regulatory networks. Bruggeman FJ, Westerhoff HV, Hoek JB, Kholodenko BN, J Theor Biol 2002 218 507 520 12384053 (Pubitemid 35286349)
47. Physical laws shape biology. Selvarajoo K, Tomita M, Science 2013 339 646
48. Interpreting the dynamics and patterns of living systems. Selvarajoo K, Bioscience 2013 63 721 722
49. Macroscopic law of conservation revealed in the population dynamics of Toll- like receptor signaling. Selvarajoo K, Cell Commun Signal 2011 9 9 10.1186/1478-811X-9-9 21507223
50. Understanding multimodal biological decisions from single cell and population dynamics. Selvarajoo K, WIREs Syst Biol Med 2012 4 385 399 10.1002/wsbm.1175
51. Uncertainty and certainty in cellular dynamics. Selvarajoo K, Front Genet 2013 4 68 DOI:10.3389/fgene.2013.00068 23630542
52. Finding self-organization from the dynamic gene expressions of innate immune responses. Selvarajoo K, Giuliani A, Front Physiol 2012 3 192 DOI:10.3389/fphys.2012.00192 22701431
53. TNF activates an IRF1- dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB, Nat Immunol 2008 9 378 387 18345002 (Pubitemid 351405107)
54. Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes. Kaneva MK, Kerrigan MJ, Grieco P, Curley GP, Locke IC, Getting SJ, Br J Pharmacol 2012 167 167 179
55. In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: I: Experimental observations. Theobald U, Mailinger W, Baltes M, Rizzi M, Reuss M, Biotechnol Bioeng 1997 55 305 316 10.1002/(SICI)1097-0290(19970720)55:2<305:: AID-BIT8>3.0.CO;2-M 18636489 (Pubitemid 27291199)
56. Sensitivity analysis approaches applied to systems biology models. Zi H, IET Syst Biol 2011 5 336 346 10.1049/iet-syb.2011.0015 22129029